[This entry is marked for removal.]
GE Medical Systems and Amersham announced in April 2004 the completion of a share exchange acquisition of
Amersham Health by GE. The result of this acquisition is the new
GE Healthcare, based in the UK, totally owned by General Electric (GE).
Amersham plc, was a producer of
contrast imaging agents used to enhance image quality in X-ray,
magnetic resonance imaging, and
ultrasound procedures. It was also a leading producer of radiopharmaceuticals used in nuclear medicine imaging.
Amersham Health was the firm's imaging, diagnostics, and therapeutics segment. Amersham plc was involved in biotechnology research through its Amersham Biosciences unit, which made scanners, sequencers, microarrays, industrial separations, and other research supplies.